Dimensional Fund Advisors LP Rubius Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.79 - $5.98 $12,840 - $97,198	-16,254 Reduced 44.56%	20,222 $17,000
Q4 2021 Feb 09, 2022	BUY	$9.68 - $17.74 $4,220 - $7,734	436 Added 1.21%	36,476 $353,000
Q3 2021 Nov 12, 2021	BUY	$17.6 - $25.91 $321,780 - $473,712	18,283 Added 102.96%	36,040 $644,000
Q1 2021 May 14, 2021	BUY	$8.02 - $32.01 $41,671 - $166,323	5,196 Added 41.37%	17,757 $471,000
Q4 2020 Feb 25, 2021	BUY	$4.23 - $8.73 $53,133 - $109,657	12,561 New	12,561 $95,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.